Assessment of LBR-101 In Chronic Migraine

Study Title

Assessment of LBR-101 In Chronic Migraine

Teva Identifier

LBR-101-021

ClinicalTrials.gov Identifier

NCT02021773

Study Status

Completed

Trial Condition(s)

Chronic Migraine

Interventions

Biological: LBR-101 High Dose | Biological: LBR-101 Low Dose | Biological: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 65 Years

Trial Duration

01/01/2014 - 03/01/2015

Phase

Phase 2

Study Type

Interventional